GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click here to find out why GDRX is a Buy.
GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning? (NASDAQ:GDRX)
Seeking Alpha Stock1 hrs ago
115
The Motley Fool
Reuters US Economy
Reuters US Business
Essentiallysports Basketball
Associated Press US News
Fast Company
The Hill